First Business Financial Services (FBIZ)
(Delayed Data from NSDQ)
$34.24 USD
+0.35 (1.03%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $34.29 +0.05 (0.15%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.24 USD
+0.35 (1.03%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $34.29 +0.05 (0.15%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Zacks News
First Business Financial Services (FBIZ) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
First Business Financial Services (FBIZ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
First Business Financial Services (FBIZ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
First Business Financial Services (FBIZ) delivered earnings and revenue surprises of 12.09% and 1.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
First Business Financial Services (FBIZ) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
First Business Financial Services (FBIZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Civista Bancshares (CIVB) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Civista Bancshares (CIVB) delivered earnings and revenue surprises of -5% and 1.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Will First Business Financial Services (FBIZ) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
First Business Financial Services (FBIZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
UMB Financial (UMBF) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
UMB (UMBF) delivered earnings and revenue surprises of 31.52% and 2.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why First Business (FBIZ) Stock Might be a Great Pick
by Zacks Equity Research
First Business (FBIZ) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Reasons to Hold on to BOK Financial (BOKF) Stock For Now
by Zacks Equity Research
BOK Financial (BOKF) benefits from continued economic recovery that drives decent loan and deposit growth. However, mounting expenses and margin pressures are major near-term concerns.
Best Momentum Stocks to Buy for March 31st
by Zacks Equity Research
FBIZ, NTDOY, and BTU made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 31, 2022.
New Strong Buy Stocks for March 31st
by Zacks Equity Research
SOI, TRVG, CHS, LCNB, and FBIZ have been added to the Zacks Rank #1 (Strong Buy) List on March 31, 2022.
Revenue Growth Aid Northern Trust (NTRS) Despite Rising Costs
by Zacks Equity Research
Northern Trust's (NTRS) revenue growth and loan demand due to rising interest rates and focus on expanding client base reflect strong organic growth. Yet, a competitive labor market keeps costs high.
Carlyle (CG) Rides on Organic Growth, Rising Expenses Ail
by Zacks Equity Research
Carlyle's (CG) organic growth, backed by increasing AUM balance and fund management fees, is a positive. Yet, a rise in expenses and competition for investment opportunities are concerning.
Organic Growth Aids T. Rowe Price (TROW) Despite High Costs
by Zacks Equity Research
T. Rowe Price's (TROW) organic growth efforts and strategic efforts will support financials. However, rising costs and overdependence on investment advisory fees are concerning.
Federated Hermes (FHI) Strategic Buyouts Aid, Cost Woes Stay
by Zacks Equity Research
Federated Hermes' (FHI) efforts to expand via acquisitions and operational expansion efforts are commendable. Yet, higher expenses and a strict regulatory environment are major drags.
Affiliated Managers (AMG) to Sell Baring Private Equity Stake
by Zacks Equity Research
Affiliated Managers (AMG) intends to use the gross proceeds from the sale of its minority stake in BPEA to pay taxes, repay debt, and fund growth investments and share buybacks.
6 Reasons Why Bank of Hawaii (BOH) Stock is Worth Buying Now
by Zacks Equity Research
Bank of Hawaii's (BOH) rising loan and deposit balances, backed by a recovery in the economy will strengthen its balance sheet. Its substantial capital deployments enhance its shareholder value.
Texas Capital's (TCBI) Strategic Plan to Aid Amid Cost Woes
by Zacks Equity Research
Texas Capital's (TCBI) strategic plan to expand its product offerings and digitalize operations will likely boost financials. However, escalating operating costs are creating headwinds.
Best Momentum Stocks to Buy for March 15th
by Zacks Equity Research
EOG, GOGO, and FBIZ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 15, 2022.
Deutsche Bank (DB) to Withdraw From Russia, Sets '25 Goals
by Zacks Equity Research
Deutsche Bank (DB) announces its financial plans and capital distribution strategy to be carried out by 2025 while winding down its business in Russia.
Citi's (C) Sale of Russian Consumer Bank Arm Delayed Amid War
by Zacks Equity Research
There will likely be a snag in Citi's (C) sale of its consumer banking unit in Russia on grounds of the escalated geopolitical tension surrounding the country's conflict with Ukraine.
Should Investors Fret Over UBS Group's (UBS) Russian Exposure?
by Zacks Equity Research
UBS Group (UBS) reveals its $634-million exposure to Russia that has subsided since 2021 end.
First Business (FBIZ) Rewards Investors With New Buyback Plan
by Zacks Equity Research
First Business' (FBIZ) new share buyback plan is expected to enhance shareholder value.
Here's Why You Should Hold Fifth Third (FITB) Stock for Now
by Zacks Equity Research
Fifth Third's (FITB) sound diversified revenue sources, rising loan and deposit balances and strong liquidity bode well. Rising costs, margin pressure and a concentrated loan portfolio are woes.
Citigroup (C) Eyes Commercial Bank Expansion With Hirings
by Zacks Equity Research
Citigroup (C) is aiming to rapidly scale operations in North America, Asia and Latin America, and foray into parts of Europe by adding 900 people in its Citi Commercial Bank segment.
5 Reasons Why Raymond James (RJF) Stock is Worth Buying Now
by Zacks Equity Research
Raymond James' (RJF) robust balance sheet, global footprint, as well as organic and inorganic expansion make it well positioned for growth. Its solid capital deployments enhance shareholder value.